Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
18 March 2019Website:
http://www.cyclerion.comNext earnings report:
26 July 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 20:08:54 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Cyclerion Therapeutics?
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's disease with vascular pathology; and Phase 1 trials diagnosed with schizophrenia in adults. It is also developing Praliciguat, an orally administered systemic sGC stimulator, which is in Phase II studies to treat resistant hypertension and diabetic nephropathy; Olinciguat, an orally administered vascular sGC stimulator that is in Phase II studies for the sickle cell disease; and CY3018 for the treatment of disorders of the CNS. It has license agreement with Akebia Therapeutics, Inc. for the development, manufacture, medical affairs, and commercialization of pharmaceutical products, including pharmaceutical compound, and other related products and forms. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
What sector is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Healthcare sector
What industry is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Biotechnology industry
What country is Cyclerion Therapeutics from?
Cyclerion Therapeutics is headquartered in United States
When did Cyclerion Therapeutics go public?
Cyclerion Therapeutics initial public offering (IPO) was on 18 March 2019
What is Cyclerion Therapeutics website?
https://www.cyclerion.com
Is Cyclerion Therapeutics in the S&P 500?
No, Cyclerion Therapeutics is not included in the S&P 500 index
Is Cyclerion Therapeutics in the NASDAQ 100?
No, Cyclerion Therapeutics is not included in the NASDAQ 100 index
Is Cyclerion Therapeutics in the Dow Jones?
No, Cyclerion Therapeutics is not included in the Dow Jones index
When does Cyclerion Therapeutics report earnings?
The next expected earnings date for Cyclerion Therapeutics is 26 July 2024